These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA, Gadad AK. J Med Chem; 2006 Jan 26; 49(2):475-89. PubMed ID: 16420035 [Abstract] [Full Text] [Related]
9. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study. Kulkarni SS, Kulkarni VM. J Med Chem; 1999 Feb 11; 42(3):373-80. PubMed ID: 9986707 [Abstract] [Full Text] [Related]
11. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase. Holder S, Lilly M, Brown ML. Bioorg Med Chem; 2007 Oct 01; 15(19):6463-73. PubMed ID: 17637507 [Abstract] [Full Text] [Related]
12. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment. Yuan H, Kozikowski AP, Petukhov PA. J Med Chem; 2004 Dec 02; 47(25):6137-43. PubMed ID: 15566285 [Abstract] [Full Text] [Related]
18. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening. Zhang QY, Wan J, Xu X, Yang GF, Ren YL, Liu JJ, Wang H, Guo Y. J Comb Chem; 2007 Sep 02; 9(1):131-8. PubMed ID: 17206841 [Abstract] [Full Text] [Related]